National Bank of Canada
INBS icon

National Bank of Canada’s Intelligent Bio Solutions INBS Stock Holding History

National Bank of Canada’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35
Closed -$332 – 3081
2025
Q4 		$332 Hold
35
– – ﹤0.01% 2717
2025
Q3 		$354 Hold
35
– – ﹤0.01% 2715
2025
Q2 		$598 Buy
+35
New +$503 ﹤0.01% 2754

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $322M AUM 16.26% 1-Year Est. Return

National Bank of Canada's INBS Position: Q1 2026 in Review

National Bank of Canada sold out of Intelligent Bio Solutions (INBS) in Q1 2026, closing a stake of 35 shares — an estimated $332 sold.

National Bank of Canada first reported a position in INBS in Q2 2025 and held it in 3 quarters. The position peaked at $598 in Q2 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q1 2026.

  • National Bank of Canada reported no remaining Intelligent Bio Solutions position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 35 Intelligent Bio Solutions shares in Q1 2026, an estimated $332.
  • National Bank of Canada first reported a position in Intelligent Bio Solutions in Q2 2025 and held it in 3 quarters.
  • National Bank of Canada's Intelligent Bio Solutions position peaked at $598 in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.